Welcome to our dedicated page for Transcat news (Ticker: TRNS), a resource for investors and traders seeking the latest updates and insights on Transcat stock.
Transcat Inc (TRNS) provides essential calibration services and compliance solutions for life sciences, pharmaceutical, and industrial sectors. This news hub offers investors and industry professionals direct access to official corporate announcements and strategic developments.
Find timely updates on regulatory compliance achievements, service network expansions, and financial performance. Our curated collection includes earnings reports, instrumentation innovations, and quality assurance milestones that demonstrate Transcat's market leadership.
Key content areas cover FDA-related compliance updates, ISO/IEC 17025 accreditation developments, distribution partnerships, and operational enhancements across Transcat's North American service centers. All materials maintain strict adherence to factual reporting standards.
Bookmark this page for streamlined access to Transcat's verified announcements. Check regularly for updates impacting measurement services, laboratory instrument validation, and industrial compliance solutions in regulated markets.
Transcat, Inc. (NASDAQ: TRNS) will release its fourth quarter and full fiscal year 2022 results after market close on May 23, 2022. A conference call will be held on May 24, 2022, at 11:00 a.m. ET to discuss the results and corporate strategy. The company focuses on accredited calibration services and asset management, serving highly regulated industries including life sciences, aerospace, and utilities. Transcat operates 23 calibration service centers across North America, enhancing its market position and customer service capabilities.
Transcat, Inc. (NASDAQ: TRNS) will present at the Sidoti Small Cap Virtual Investor Conference on March 23 and 24, 2022. CEO Lee D. Rudow and CFO Mark A. Doheny will be available for investor meetings, with the presentation scheduled for March 23 at 12:15 p.m. ET. A live webcast and presentation materials can be accessed on the company's investor relations page. Transcat specializes in accredited calibration, enterprise asset management, and distribution of test instrumentation, serving highly regulated industries including life sciences and aerospace.
Transcat, Inc. (TRNS) reported third-quarter revenue of $50.9 million, a 15.5% increase from the previous year. The service segment's organic revenue grew by 10.2%, contributing to a gross margin expansion of 180 basis points to 29.7%. Adjusted EBITDA rose by 20% to $5.5 million. Despite robust demand, the distribution segment's revenue growth of 7.2% was below expectations due to longer vendor lead times. The company anticipates continued strong performance in the upcoming fiscal quarter and maintains a healthy backlog of $9 million.
Transcat, Inc. (NASDAQ: TRNS) will announce its third quarter fiscal year 2022 results on February 1, 2022, after market close. The company will host a conference call on February 2, 2022, at 11:00 a.m. ET, to review financial and operational results alongside its corporate strategy and future outlook. Transcat, a leader in providing calibration, repair, and laboratory services, aims to leverage its dual service and distribution segments to fuel organic sales growth and expand its market share through strategic acquisitions.
Transcat, Inc. (Nasdaq: TRNS) has acquired Tangent Labs, LLC for $9 million, effective December 31, 2021. Tangent, specializing in precision calibration for regulated sectors such as life science and aerospace, generates approximately $2.2 million in annual revenue. This acquisition aligns with Transcat's expansion strategy, providing new presences in key markets, particularly in Indiana and Huntsville, Alabama. Kevin Broderick, Tangent's owner, will integrate into Transcat's leadership, enhancing the company's existing service capabilities to drive further profitability.
Transcat, Inc. (NASDAQ: TRNS) will participate in the Sidoti Virtual Micro Cap Investor Conference on December 8, 2021. CEO Lee D. Rudow and CFO Mark A. Doheny will present at 9:15 a.m. ET and are available for investor meetings. A link to the live webcast and presentation materials can be found on their investor relations page. Transcat specializes in accredited calibration, repair, inspection, and laboratory services, catering to regulated industries such as Life Sciences and Aerospace.
Transcat, Inc. (NASDAQ: TRNS) reported a strong second quarter for fiscal 2022, with consolidated revenue reaching $50.4 million, a 21.1% increase year-over-year. The Service segment revenue rose 20.3% to $29.5 million, while the Distribution segment saw a 22.2% increase to $20.8 million. Gross margins improved, with the Service segment at 32.9% and Distribution at 23.5%. Adjusted EBITDA rose 35.5% to $7.1 million. Operating expenses included one-time costs from the NEXA acquisition, totaling $0.8 million. The company expects continued growth in the third quarter, driven by organic and acquisition-related revenue.
Transcat, Inc. (NASDAQ: TRNS) is set to release its second quarter fiscal year 2022 results on
Transcat, Inc. (NASDAQ: TRNS), a leader in calibration and laboratory services, will present at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021. CEO Lee D. Rudow and CFO Mark A. Doheny will deliver a pre-recorded presentation available from 7:00 am ET on September 13th. The presentation materials will also be accessible on Transcat's investor relations website, with a replay available for 60 days. Transcat focuses on regulated industries and aims to enhance organic sales growth through strategic acquisitions and investments.
FAQ
What is the current stock price of Transcat (TRNS)?
What is the market cap of Transcat (TRNS)?
